Cargando…

Potential of neutrophil to lymphocyte ratio in predicting sustained remission in rheumatoid arthritis compared to other immune activation markers

BACKGROUND & OBJECTIVES: Cells and cell proportions may indicate the equilibrium status of the immune system. The present study was conducted to evaluate the role of cytokines and the immunocompetent cells as biomarkers of remission in rheumatoid arthritis (RA) patients intended to withdraw or r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandrashekara, S., Lingaraju, Deepak Chikkulikere, Renuka, P., Anupama, K.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881809/ https://www.ncbi.nlm.nih.gov/pubmed/33107483 http://dx.doi.org/10.4103/ijmr.IJMR_1676_18

Ejemplares similares

Platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in patients with rheumatoid arthritis
por: Peng, You-Fan, et al.
Publicado: (2015)

Red cell distribution width and neutrophil-lymphocyte ratio as inflammatory markers in patients with rheumatoid arthritis
por: Kushwaha, Shekhar, et al.
Publicado: (2023)

Patient’s perspective of sustained remission in rheumatoid arthritis
por: Contreras-Yáñez, Irazú, et al.
Publicado: (2017)

Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Chen, Qiang, et al.
Publicado: (2019)

Assessing the Role of DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio in Rheumatoid Arthritis
por: Ambatipudi, Srikant, et al.
Publicado: (2018)

Sustained rheumatoid arthritis remission is uncommon in clinical practice
por: Prince, Femke HM, et al.
Publicado: (2012)

Defining and characterizing sustained remission in patients with rheumatoid arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2017)

Correction: Prevalence and predictors for sustained remission in rheumatoid arthritis
por: Sung, Yoon-Kyoung, et al.
Publicado: (2019)

Sustained Remission in Rheumatoid Arthritis: Time to Withdraw Treatment?
por: Sungur, Can M.
Publicado: (2021)

Diagnostic Value of Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and Monocyte-to-Lymphocyte Ratios for the Assessment of Rheumatoid Arthritis in Patients with Undifferentiated Inflammatory Arthritis
por: Song, Byung-Wook, et al.
Publicado: (2022)

Neutrophil-lymphocyte, platelet-lymphocyte and lymphocyte-monocyte ratios may not be useful markers to assess disease activity in rheumatoid arthritis: A STROBE-compliant article
por: Lijuan, Wang, et al.
Publicado: (2021)

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
por: Curtis, Jeffrey R., et al.
Publicado: (2021)

The Relationship between Hematological Markers of Systemic Inflammation (Neutrophil-To-Lymphocyte, Platelet-To-Lymphocyte, Lymphocyte-To-Monocyte Ratios) and Ultrasound Disease Activity Parameters in Patients with Rheumatoid Arthritis
por: Targońska-Stępniak, Bożena, et al.
Publicado: (2020)

Remission in Rheumatoid Arthritis
por: Shammas, Rania M., et al.
Publicado: (2010)

Regulatory and other rheumatoid factors in rheumatoid arthritis patients with active disease or in remission
por: Beduleva, Liubov, et al.
Publicado: (2021)

Demographics and clinical characteristics associated with sustained remission and continuation of sustained remission in patients with rheumatoid arthritis treated with adalimumab
por: Kimura, Noriko, et al.
Publicado: (2019)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
por: Xie, Tan, et al.
Publicado: (2023)

The value of the neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as complementary diagnostic tools in the diagnosis of rheumatoid arthritis: A multicenter retrospective study
por: Jin, Zihan, et al.
Publicado: (2020)

Neutrophil‐to‐monocyte ratio is the better new inflammatory marker associated with rheumatoid arthritis activity
por: Obaid, Jamil M. A. S., et al.
Publicado: (2023)

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis
por: Accortt, Neil A., et al.
Publicado: (2018)

Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria
por: Svensson, Björn, et al.
Publicado: (2013)

Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients
por: Wang, Wen-Ming, et al.
Publicado: (2021)

Severe Mononeuritis Multiplex due to Rheumatoid Vasculitis in Rheumatoid Arthritis in Sustained Clinical Remission for Decades
por: Tanemoto, Masanobu, et al.
Publicado: (2019)

Ultrasound remission in patients with rheumatoid arthritis in clinical remission
por: Fakhfakh, Rym, et al.
Publicado: (2021)

The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Associations of Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Monocyte-to-Lymphocyte Ratio with Osteoporosis and Incident Vertebral Fracture in Postmenopausal Women with Rheumatoid Arthritis: A Single-Center Retrospective Cohort Study
por: Song, Byung-Wook, et al.
Publicado: (2022)

Neutrophils to Lymphocyte Ratio: Earliest and Efficacious Markers of Sepsis
por: Rehman, Fazal U, et al.
Publicado: (2020)

Blood Lymphocyte Subsets for Early Identification of Non-Remission to TNF Inhibitors in Rheumatoid Arthritis
por: Rodríguez-Martín, Eulalia, et al.
Publicado: (2020)

The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis
por: Zeb, Alam, et al.
Publicado: (2019)

Sustained biologic-free and drug-free remission in rheumatoid arthritis, where are we now?
por: Nagy, György, et al.
Publicado: (2015)

Physical function continues to improve when clinical remission is sustained in rheumatoid arthritis patients
por: Radner, Helga, et al.
Publicado: (2015)

Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients
por: Burkard, Theresa, et al.
Publicado: (2021)

Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis
por: Banko, Ana, et al.
Publicado: (2023)

Neutrophil-to-lymphocyte ratio as a predictive marker of metabolic syndrome
por: Liu, Chuan-Chuan, et al.
Publicado: (2019)

Validity of Remission Criteria in Rheumatoid Arthritis Compared to Ultrasound-Defined Remission
por: Ben Abdelghani, Kawther, et al.
Publicado: (2022)

A multi-biomarker disease activity score can predict sustained remission in rheumatoid arthritis
por: Ma, M. H. Y., et al.
Publicado: (2020)

The Economic Benefit of Remission for Patients with Rheumatoid Arthritis
por: Curtis, Jeffrey R., et al.
Publicado: (2022)

Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio
por: Oh, Dongwook, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kiljskilgnsfmlmme54h3kiogk